Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking
Over the past six months, Pfizer’s shares (currently trading at $26.70) have posted a disappointing 10.2% loss, well below the S&P 500’s 3.8% gain. This
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking
Since September 2024, DaVita has been in a holding pattern, posting a small loss of 4.3% while floating around $147.02. The stock also fell short of the
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the wireless, cable and satellite stocks, including AT&T (NYSE:T) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s
Abbott Laboratories’s 16.6% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $136.50 per share. This
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the modern fast food industry, including Shake Shack
(Reuters) -A cautious sales outlook for the commercial vehicle market in 2025 amid a weak global economy sent shares of Volkswagen's truck unit Traton
